| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/24/2010 | EP2155789A2 Immunoglobulin fc libraries |
| 02/24/2010 | EP2155788A2 Cross-species-specific bispecific binders |
| 02/24/2010 | EP2155787A1 H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance |
| 02/24/2010 | EP2155786A2 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 02/24/2010 | EP2155785A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer |
| 02/24/2010 | EP2155783A2 Cross-species-specific cd3-epsilon binding domain |
| 02/24/2010 | EP2155774A1 Polymer two phase system and use thereof |
| 02/24/2010 | EP2155773A1 Separation method using polymer multi phase systems |
| 02/24/2010 | EP2155691A1 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 02/24/2010 | EP2155249A1 Compositions and methods for diagnosing and treating cancer |
| 02/24/2010 | EP2155248A1 Targeting abcb5 for cancer therapy |
| 02/24/2010 | EP2155247A1 Prevention of staphylococcus biofilm formation |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1485481B1 Fluorescent protein from aequorea coerulescens and uses thereof |
| 02/24/2010 | EP1471936B1 Hiv vaccine and method of use |
| 02/24/2010 | EP1325130B1 Nogo receptor homologs |
| 02/24/2010 | EP1112087B1 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | CN101657469A Novel antibodies against IGF-1R |
| 02/24/2010 | CN101657468A Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 02/24/2010 | CN101657467A Human cytomegalovirus neutralising antibodies and use thereof |
| 02/24/2010 | CN101654483A compositions and methods for generating chimeric heteromultimers |
| 02/24/2010 | CN101654482A High specific anti-tumor monoclonal antibody |
| 02/24/2010 | CN101654481A Natural anti-oxidation low-density lipoprotein antibody for suppressing atherosclerosis |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653604A Anti-ngf antibodies for the treatment of various disorders |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN100592086C Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |
| 02/24/2010 | CN100591694C Igy antibody and method for selectively separating it from eggs of anseriformes |
| 02/24/2010 | CN100591693C Antibodies that bind cell-associated CA125/0722P and methods of use thereof |
| 02/23/2010 | US7667114 Starch branching enzyme |
| 02/23/2010 | US7667088 bioassay; induction of antibodies against desmoglein; activation of lymphocytes; oral diseases |
| 02/23/2010 | US7667021 Neutralizing human anti-IGFR antibody |
| 02/23/2010 | US7667018 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response |
| 02/23/2010 | US7667016 nucleic acid compositions encoding a unique colorless protein, can be photoactivated, used in many biochemical, molecular biological and medical diagnostic applications |
| 02/23/2010 | US7667015 Genetic engineering; induce immunology response; biodrug as anticarcinogenic agents, for pancreatic cancer |
| 02/23/2010 | US7667013 Gene encoding a guanine nucleotide exchange factor and the gene product thereof |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667007 αvβ3-specific antibodies |
| 02/23/2010 | US7667006 Anti-HIV antibody |
| 02/23/2010 | US7667005 Polypeptide, novel DNA and novel antibody |
| 02/23/2010 | US7667004 Humanized antibodies against vascular endothelial growth factor |
| 02/23/2010 | US7667003 Antibody directed to human mist (mast cell immunoreceptor signal transducer) |
| 02/23/2010 | US7667002 Peptides and proteins for early liver development and antibodies thereto |
| 02/23/2010 | US7667001 markers overexpressed in lung cancer that are both sensitive and accurate; high degree of differential detection between lung cancer and non-cancerous states; kits |
| 02/23/2010 | US7667000 Antibodies to Zcytor 16 |
| 02/23/2010 | US7666999 Neutral amino acid transporter and gene thereof |
| 02/23/2010 | US7666998 Cell growth inhibitor containing anti-PepT antibody |
| 02/23/2010 | US7666997 Antitumor agents |
| 02/23/2010 | US7666995 Interferons, uses and compositions related thereto |
| 02/23/2010 | US7666994 fusion protein comprising isolated GnRH receptor protein; culturing transformant comprising vector; screening for ligands; cancer and reproductive treatment |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666633 Enzymes having alpha amylase activity and methods of making and using them |
| 02/23/2010 | US7666626 P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typable H. influenzae (NTHi) |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666623 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 02/23/2010 | US7666621 Has an apparent molecular weight of 42,000 Daltons; fusion protein of the protein D bound to a polypeptide, carbohydrate, or matrix; prepared by providing a non-human host containing a plasmid or phage comprising a DNA nucleotide sequence and expressing the encoded protein D |
| 02/23/2010 | US7666609 Method and composition for diagnosis of melanocytic lesions |
| 02/23/2010 | US7666607 tumor necrosis factor receptors; drug screening modulators of jun n-terminal kinase and nuclear factor kappa beta |
| 02/23/2010 | US7666605 Method for prognostic evaluation of carcinoma using anti-P-LAP antibody |
| 02/23/2010 | US7666438 Generating an immune response by administering to a host an immunologically effective amount of an isolated fibrinogen binding domain of the clumping factor A protein (ClfA) from Staphylococcus aureus and an immunologically effective amount of an isolated S. aureus capsular polysaccharide type 5 |
| 02/23/2010 | US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/23/2010 | US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor |
| 02/23/2010 | US7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 02/23/2010 | US7666425 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 02/23/2010 | US7666424 Directed against a target antigen, cell culture to express, code the protein, for treating cancer |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666421 Comprising a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin; treating various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases |
| 02/23/2010 | US7666420 Composition for treating pathology associated with MSRV/HERV-W |
| 02/23/2010 | US7666419 Anti-CCR5 antibody |
| 02/23/2010 | US7666418 Method for treating Th2-mediated disease |
| 02/23/2010 | US7666417 Such as rheumatoid arthritis and diabetes; antibodies; kits |
| 02/23/2010 | US7666416 Mammalian cell culture process |
| 02/23/2010 | US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 02/23/2010 | US7666414 Using modified anti-PSMA antibodies, or fragments thereof, to bind to human PSMA with high affinity and specificity; can be used as diagnostic, prophylactic, or therapeutic agents in vivo and in vitro |
| 02/23/2010 | US7666413 For subcutaneous administration; hypertonic; useful for preventing self-association of reconstituted lyophilized formulations |
| 02/23/2010 | US7666411 Administering to the subject an effective amount of a substance that binds to IL-13, wherein the substance that binds to IL-13 is an antibody and inhibits IL-13 activation of IL-13R alpha |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | US7666400 PEGylation by the dock and lock (DNL) technique |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2268339C Compositions and methods for detection of antibody binding to cells |
| 02/23/2010 | CA2198899C Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 02/23/2010 | CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor |
| 02/18/2010 | WO2010019952A2 Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response |
| 02/18/2010 | WO2010019656A1 Humanized anti-rage antibody |
| 02/18/2010 | WO2010019493A1 Methods for purifying antibodies using protein a affinity chromatography |
| 02/18/2010 | WO2010018870A1 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 02/18/2010 | WO2010018846A1 Drug containing antibody composition specifically binding to ganglioside gm2 |
| 02/18/2010 | WO2010018207A1 Endoglin peptides, vaccines and methods for preparing the same |
| 02/18/2010 | WO2010017819A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2010017595A1 Variant domain antibodies |
| 02/18/2010 | WO2009157771A3 Antibody producing non-human mammals |
| 02/18/2010 | WO2009155324A3 Pigf-1 assay and kits and components thereof |
| 02/18/2010 | WO2009145838A3 Cellular production of glucaric acid |
| 02/18/2010 | WO2009139891A3 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof |
| 02/18/2010 | WO2009134962A3 Claudin-4 binding peptides, compositions and methods of use |
| 02/18/2010 | WO2009134891A3 Immunomodulating compositions and methods of use thereof |